Analyst Ratings for First Tracks Biotherapeutics (TRAX)
TRAX Rating Summary
TRAX Price Target Summary
- Highest: $100.00 (Guggenheim)
- Lowest: $30.00 (Wedbush)
- Average: $61.83
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$61.83 (+98%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/30/2026 | Canaccord | Edward Nash | New Coverage | Buy (N/A) |
50.00 (N/A) |
35.98 (31.23) |
-13.2% | Details |
| 9/18/2026 | Evercore ISI | Gavin Clark-Gartner | New Coverage | Outperform (N/A) |
65.00 (N/A) |
39.20 (31.23) |
-20.33% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
